The 10 most prescribed drugs in the U.S. aren't the drugs on which we spend the most, according to a report from the IMS Institute for Healthcare Informatics.
The institute is the public face of IMS, a pharmaceutical market intelligence firm. Its latest report provides a wealth of data on U.S. prescription drug use.
Continuing a major trend, IMS finds that 78% of the nearly 4 billion U.S. prescriptions written in 2010 were for generic drugs (both unbranded and those still sold under a brand name). In order of number of prescriptions written in 2010, the 10 most-prescribed drugs in the U.S. are:
Hydrocodone (combined with acetaminophen) -- 131.2 million prescriptions
Generic Synthroid (levothyroxine sodium), synthetic thyroid hormone -- 70.5 million prescriptions
Generic Norvasc (amlodipine besylate), an angina/blood pressure drug -- 57.2 million prescriptions
Generic Prilosec (omeprazole), an antacid drug -- 53.4 million prescriptions (does not include over-the-counter sales)
Azithromycin (brand names include Z-Pak and Zithromax), an antibiotic -- 52.6 million prescriptions
Amoxicillin (various brand names), an antibiotic -- 52.3 million prescriptions
Generic Glucophage (metformin), a diabetes drug -- 48.3 million prescriptions
Hydrochlorothiazide (various brand names), a water pill used to lower blood pressure -- 47.8 million prescriptions.
The 10 Best-Selling Drugs
It shouldn't be a surprise that these generic drugs are not the ones bringing in the big bucks for pharmaceutical companies. The drugs on which we spend the most money are those that are still new enough to be protected against generic competition.
The IMS reports that Americans spent $307 billion on prescription drugs in 2010. The 10 drugs on which we spent the most were:
Lipitor, a cholesterol-lowering statin drug -- $7.2 billion
Nexium, an antacid drug -- $6.3 billion
Plavix, a blood thinner -- $6.1 billion
Advair Diskus, an asthma inhaler -- $4.7 billion
Abilify, an antipsychotic drug -- $4.6 billion
Seroquel, an antipsychotic drug -- $4.4 billion
Singulair, an oral asthma drug -- $4.1 billion
Crestor, a cholesterol-lowering statin drug -- $3.8 billion
Actos, a diabetes drug -- $3.5 billion
Epogen, an injectable anemia drug -- $3.3 billion
The institute is the public face of IMS, a pharmaceutical market intelligence firm. Its latest report provides a wealth of data on U.S. prescription drug use.
Continuing a major trend, IMS finds that 78% of the nearly 4 billion U.S. prescriptions written in 2010 were for generic drugs (both unbranded and those still sold under a brand name). In order of number of prescriptions written in 2010, the 10 most-prescribed drugs in the U.S. are:
Hydrocodone (combined with acetaminophen) -- 131.2 million prescriptions
Generic Zocor (simvastatin), a cholesterol-lowering statin drug -- 94.1 million prescriptions
Lisinopril (brand names include Prinivil and Zestril), a blood pressure drug -- 87.4 million prescriptionsGeneric Synthroid (levothyroxine sodium), synthetic thyroid hormone -- 70.5 million prescriptions
Generic Norvasc (amlodipine besylate), an angina/blood pressure drug -- 57.2 million prescriptions
Generic Prilosec (omeprazole), an antacid drug -- 53.4 million prescriptions (does not include over-the-counter sales)
Azithromycin (brand names include Z-Pak and Zithromax), an antibiotic -- 52.6 million prescriptions
Amoxicillin (various brand names), an antibiotic -- 52.3 million prescriptions
Generic Glucophage (metformin), a diabetes drug -- 48.3 million prescriptions
Hydrochlorothiazide (various brand names), a water pill used to lower blood pressure -- 47.8 million prescriptions.
The 10 Best-Selling Drugs
It shouldn't be a surprise that these generic drugs are not the ones bringing in the big bucks for pharmaceutical companies. The drugs on which we spend the most money are those that are still new enough to be protected against generic competition.
The IMS reports that Americans spent $307 billion on prescription drugs in 2010. The 10 drugs on which we spent the most were:
Lipitor, a cholesterol-lowering statin drug -- $7.2 billion
Nexium, an antacid drug -- $6.3 billion
Plavix, a blood thinner -- $6.1 billion
Advair Diskus, an asthma inhaler -- $4.7 billion
Abilify, an antipsychotic drug -- $4.6 billion
Seroquel, an antipsychotic drug -- $4.4 billion
Singulair, an oral asthma drug -- $4.1 billion
Crestor, a cholesterol-lowering statin drug -- $3.8 billion
Actos, a diabetes drug -- $3.5 billion
Epogen, an injectable anemia drug -- $3.3 billion
Comments
Post a Comment